How to find #Stocks for Short Term Momentum

A thread with 10 Screeners 🧵🧵🧵

Kindly Re-Tweet like for Max Reach 🙏

1) For Short to Mid Term Stocks
https://t.co/4VPiXD1T6R
2) 52 week Breakout Stocks

https://t.co/Qaq3h5dMD3
3) Bollinger Band Breakout Stocks
https://t.co/JuRAV323yP
4) Short Term BO Stocks
https://t.co/VZ7PLIRQHC
5) Range BO with volume Stocks
https://t.co/WIfA1NacAe
6) Bullish for next day Stocks
https://t.co/4hj52dZf2y
7) Bullish Engulfing Stocks

https://t.co/VUbkeQAKl0
8) Bullish Momentum Stocks
https://t.co/jY9aSML7mM
9) Strong Stocks
https://t.co/ONO2kOq2FR
Join Telegram for more learning

https://t.co/i2GEoB7pS2

More from My First Stock

How to Find Multibagger Stocks

How to create screeners and use them

How to read charts 🧵🧵

A thread of all my Threads

Kindly Re-Tweet to help others 🙏

1) How to find #Stocks for Short Term


2) Important Scanners for Stock Selection


3) How to Create Screeners on Chart Ink


4) Here are the 10 Candlestick patterns you must

You May Also Like

@EricTopol @NBA @StephenKissler @yhgrad B.1.1.7 reveals clearly that SARS-CoV-2 is reverting to its original pre-outbreak condition, i.e. adapted to transgenic hACE2 mice (either Baric's BALB/c ones or others used at WIV labs during chimeric bat coronavirus experiments aimed at developing a pan betacoronavirus vaccine)

@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice


@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2


@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj


@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o